BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 30584257)

  • 1. Inhibition of SIRT2 limits tumour angiogenesis via inactivation of the STAT3/VEGFA signalling pathway.
    Hu F; Sun X; Li G; Wu Q; Chen Y; Yang X; Luo X; Hu J; Wang G
    Cell Death Dis; 2018 Dec; 10(1):9. PubMed ID: 30584257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B7-H3 promotes colorectal cancer angiogenesis through activating the NF-κB pathway to induce VEGFA expression.
    Wang R; Ma Y; Zhan S; Zhang G; Cao L; Zhang X; Shi T; Chen W
    Cell Death Dis; 2020 Jan; 11(1):55. PubMed ID: 31974361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA PVT1 promotes angiogenesis via activating the STAT3/VEGFA axis in gastric cancer.
    Zhao J; Du P; Cui P; Qin Y; Hu C; Wu J; Zhou Z; Zhang W; Qin L; Huang G
    Oncogene; 2018 Jul; 37(30):4094-4109. PubMed ID: 29706652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of NCK1 as a novel downstream effector of STAT3 in colorectal cancer metastasis and angiogenesis.
    Zhang F; Lu YX; Chen Q; Zou HM; Zhang JM; Hu YH; Li XM; Zhang WJ; Zhang W; Lin C; Li XN
    Cell Signal; 2017 Aug; 36():67-78. PubMed ID: 28455144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRH promotes human colon cancer cell proliferation via IL-6/JAK2/STAT3 signaling pathway and VEGF-induced tumor angiogenesis.
    Fang X; Hong Y; Dai L; Qian Y; Zhu C; Wu B; Li S
    Mol Carcinog; 2017 Nov; 56(11):2434-2445. PubMed ID: 28618089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated kindlin-2 promotes tumour progression and angiogenesis through the mTOR/VEGFA pathway in melanoma.
    Wei CY; Zhu MX; Zhang PF; Yang X; Wang L; Ying JH; Luan WJ; Chen C; Liu JQ; Zhu M; Yang YW; Feng ZH; Qi FZ; Gu JY
    Aging (Albany NY); 2019 Aug; 11(16):6273-6285. PubMed ID: 31427543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIB3 Interacts with STAT3 to Promote Cancer Angiogenesis.
    Chen QZ; Chen Y; Li X; Liu H; Sun XL
    Curr Med Sci; 2022 Oct; 42(5):932-940. PubMed ID: 36245025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty acid binding protein 5 promotes tumor angiogenesis and activates the IL6/STAT3/VEGFA pathway in hepatocellular carcinoma.
    Pan L; Xiao H; Liao R; Chen Q; Peng C; Zhang Y; Mu T; Wu Z
    Biomed Pharmacother; 2018 Oct; 106():68-76. PubMed ID: 29957468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The targetable nanoparticle BAF312@cRGD-CaP-NP represses tumor growth and angiogenesis by downregulating the S1PR1/P-STAT3/VEGFA axis in triple-negative breast cancer.
    Gong K; Jiao J; Xu C; Dong Y; Li D; He D; Zhao D; Yu J; Sun Y; Zhang W; Bai M; Duan Y
    J Nanobiotechnology; 2021 May; 19(1):165. PubMed ID: 34059068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD24 promoted cancer cell angiogenesis via Hsp90-mediated STAT3/VEGF signaling pathway in colorectal cancer.
    Wang X; Zhang Y; Zhao Y; Liang Y; Xiang C; Zhou H; Zhang H; Zhang Q; Qing H; Jiang B; Xiong H; Peng L
    Oncotarget; 2016 Aug; 7(34):55663-55676. PubMed ID: 27494878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXF1 promotes angiogenesis and accelerates bevacizumab resistance in colorectal cancer by transcriptionally activating VEGFA.
    Wang S; Xiao Z; Hong Z; Jiao H; Zhu S; Zhao Y; Bi J; Qiu J; Zhang D; Yan J; Zhang L; Huang C; Li T; Liang L; Liao W; Ye Y; Ding Y
    Cancer Lett; 2018 Dec; 439():78-90. PubMed ID: 30253191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of JAK2/STAT3 reduces tumor-induced angiogenesis and myeloid-derived suppressor cells in head and neck cancer.
    Liu JF; Deng WW; Chen L; Li YC; Wu L; Ma SR; Zhang WF; Bu LL; Sun ZJ
    Mol Carcinog; 2018 Mar; 57(3):429-439. PubMed ID: 29215754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gadd45a suppresses tumor angiogenesis via inhibition of the mTOR/STAT3 protein pathway.
    Yang F; Zhang W; Li D; Zhan Q
    J Biol Chem; 2013 Mar; 288(9):6552-60. PubMed ID: 23329839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ETS variant 5 promotes colorectal cancer angiogenesis by targeting platelet-derived growth factor BB.
    Cheng X; Jin Z; Ji X; Shen X; Feng H; Morgenlander W; Ou B; Wu H; Gao H; Ye F; Zhang Y; Peng Y; Liang J; Jiang Y; Zhang T; Qiu W; Lu X; Zhao R
    Int J Cancer; 2019 Jul; 145(1):179-191. PubMed ID: 30650178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oleanolic acid inhibits colorectal cancer angiogenesis in vivo and in vitro via suppression of STAT3 and Hedgehog pathways.
    Li L; Lin J; Sun G; Wei L; Shen A; Zhang M; Peng J
    Mol Med Rep; 2016 Jun; 13(6):5276-82. PubMed ID: 27108756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The subcellular redistribution of NLRC5 promotes angiogenesis via interacting with STAT3 in endothelial cells.
    Xu X; Shi Y; Luan P; Kou W; Li B; Zhai M; You S; Yu Q; Zhuang J; Jian W; Feinberg MW; Peng W
    Theranostics; 2021; 11(9):4483-4501. PubMed ID: 33754073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DDA suppresses angiogenesis and tumor growth of colorectal cancer in vivo through decreasing VEGFR2 signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Oncotarget; 2016 Sep; 7(39):63124-63137. PubMed ID: 27517319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT3-targeting RNA interference inhibits pancreatic cancer angiogenesis in vitro and in vivo.
    Huang C; Jiang T; Zhu L; Liu J; Cao J; Huang KJ; Qiu ZJ
    Int J Oncol; 2011 Jun; 38(6):1637-44. PubMed ID: 21479358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-YA promotes invasion and angiogenesis by upregulating EZH2-STAT3 signaling in human melanoma cells.
    Xu Z; Sun Y; Guo Y; Qin G; Mu S; Fan R; Wang B; Gao W; Wu H; Wang G; Zhang Z
    Oncol Rep; 2016 Jun; 35(6):3630-8. PubMed ID: 27109360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer.
    Pichler M; Rodriguez-Aguayo C; Nam SY; Dragomir MP; Bayraktar R; Anfossi S; Knutsen E; Ivan C; Fuentes-Mattei E; Lee SK; Ling H; Catela Ivkovic T; Huang G; Huang L; Okugawa Y; Katayama H; Taguchi A; Bayraktar E; Bhattacharya R; Amero P; He WR; Tran AM; Vychytilova-Faltejskova P; Klec C; Bonilla DL; Zhang X; Kapitanovic S; Loncar B; Gafà R; Wang Z; Cristini V; Hanash SM; Bar-Eli M; Lanza G; Slaby O; Goel A; Rigoutsos I; Lopez-Berestein G; Calin GA
    Gut; 2020 Oct; 69(10):1818-1831. PubMed ID: 31988194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.